Waters forward PE WAT

Share price divided by analysts' consensus earnings for the next twelve months, since 1996.

Today, Oct 23, 2026: 29.2×
10-year median: 26.3×
Against its 10-year history: 81st; percentile: 0 is its lowest day, 100 its highest
10-year range: 19.8× to 39.1×
Peer median: 26.4×

Waters' forward PE is 29.2× as of Oct 23, 2026.

That is above its ten-year median of 26.3×, higher than on 81% of days in the last ten years.

Over that time it ranged from 19.8× in Dec 2016 to 39.1× in Sep 2021.

The median for 10 diagnostics and research stocks of a similar size is 26.4×.

Forward PE over time

median 26.3×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	29.2×	20.5×	29.2×
2025	27.9×	21.6×	33.5×
2024	30.2×	24.9×	32.6×
2023	30.2×	22.7×	30.3×
2022	29.8×	23.4×	31.4×
2021	33.7×	27.4×	39.1×
2020	27.2×	22.0×	30.1×
2019	29.3×	21.5×	29.4×
2018	22.0×	21.1×	28.4×
2017	25.3×	20.3×	26.1×
2016	19.8×	18.3×	24.1×
2015	21.7×	19.5×	23.4×
2014	20.9×	18.4×	21.1×
2013	19.0×	16.5×	20.3×
2012	16.4×	14.5×	18.3×
2011	15.0×	14.5×	20.2×
2010	17.4×	14.5×	18.1×
2009	16.7×	9.9×	16.7×
2008	12.1×	12.1×	25.6×
2007	25.8×	20.2×	26.0×

Against its peers

Companies in Medical - Diagnostics & Research nearest Waters' size, closest first, today.

Company	Forward PE
WATWaters	29.2×
IDXXIDEXX Laboratories	35.9×
IQVIQVIA	20.5×
AAgilent Technologies	26.4×
ILMNIllumina	47.2×
MTDMettler-Toledo International	33.9×
DGXQuest Diagnostics	n/m
LHLabcorp	17.4×
MEDPMedpace	n/m
RVTYRevvity	n/m
DHRDanaher	25.4×
Peer median	26.4×

Where Waters ranks

#42of 51Healthcare stocks with the lowest forward PE

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Waters

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.